← back to search

Edward B. Holson

University of Colorado Denver · US
Area of research
Molecular Biology · Materials Chemistry
Research interest
Research interests include Biology, Histone deacetylase, HDAC3, Cancer research, Histone deacetylase 2, and Chemistry.
h-index
citations
2,260
works
14
NIH funding
primary concept
email

Recent publications

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome
Science Translational Medicine 2020cited by 61position: middledoi
Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia
Science Translational Medicine 2018cited by 95position: lastdoi
Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate
eLife 2016cited by 761position: middledoi
<i>CREBBP</i> Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
Cancer Discovery 2016cited by 269position: middledoi
Activity of Caffeic Acid Phenethyl Ester in <i>Caenorhabditis Elegans</i>
Future Medicinal Chemistry 2016cited by 19position: middledoi
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
Blood 2015cited by 106position: middledoi
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection
ACS Chemical Biology 2015cited by 85position: lastdoi
Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories
Cell 2014cited by 359position: middledoi
Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers
Chemical Science 2014cited by 100position: lastdoi
Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
PLoS ONE 2014cited by 79position: middledoi
Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
ACS Chemical Neuroscience 2014cited by 59position: middledoi
Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation
Chemistry & Biology 2013cited by 113position: middledoi
Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy
Proceedings of the National Academy of Sciences 2013cited by 110position: middledoi
Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma
Blood 2013cited by 2position: middledoi
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
Proceedings of the National Academy of Sciences 2012cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Florence F. Wagner · University of Colorado Denver10 papers (2012–2020)Stephen J. Haggarty · Harvard University3 papers (2014–2014)Jennifer Gale · Massachusetts Institute of Technology3 papers (2014–2015)Jacob M. Hooker · University of Colorado Denver2 papers (2014–2015)Li‐Huei Tsai · Broad Institute2 papers (2014–2014)Taner Kaya · Massachusetts Institute of Technology2 papers (2014–2015)Stewart L. Fisher · Albert Einstein College of Medicine2 papers (2014–2015)Edward M. Scolnick · Broad Institute2 papers (2014–2020)Patrick McCarren · Novartis (Switzerland)2 papers (2014–2015)Supriya Gupta · Massachusetts Institute of Technology2 papers (2012–2013)Michael C. Lewis · Henry Ford Hospital2 papers (2014–2020)Bridget K. Wagner · Broad Institute2 papers (2012–2015)Alykhan F. Shamji · Massachusetts Institute of Technology1 papers (2012–2012)Daniel M. Fass · Massachusetts Institute of Technology1 papers (2014–2014)Marie McConkey · Dana-Farber Cancer Institute1 papers (2015–2015) · 1 papers (2015–2015)Richard Rodríguez · Stanford Medicine1 papers (2013–2013)Jeremy R. Duvall · Massachusetts Institute of Technology1 papers (2013–2013)Moses V. Chao · New York University1 papers (2016–2016)Christine McIntosh · University of Chicago1 papers (2013–2013)